Journal
OPHTHALMOLOGY RETINA
Volume 6, Issue 8, Pages 711-722Publisher
ELSEVIER INC
DOI: 10.1016/j.oret.2022.03.008
Keywords
Cone-rod dystrophy; GUCY2D; Inherited retinal dystrophies; Leber congenital amaurosis; Phenotype
Categories
Funding
- ODAS foundation [2018-2]
- European Society of Retina Specialists (EURETINA Clinical Research Award 2019) [2019-1974]
- Ghent University Special Research Fund [BOF15/GOA/011, BOF20/GOA/023]
- Fonds voor Wetenschappelijk Onderzoek [1802220N, 1803821N]
- Ghent University Hospital Innovation Fund
- National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust
- UCL Institute of Ophthalmology
- Moorfields Eye Charity
- Oxfordshire and South Midlands Clinical Research Network
- UK Inherited Retinal Dystrophy Consortium Project (Retina UK)
- Retina UK
- Qatar National Research Fund
- Uitzicht (ODAS, Oogfonds, Retinafonds)
- Uitzicht (Bartimeus Sonneheerdt)
- Health Program of the European Union [GR586]
- [GSRA6-1-0329-19010]
- [2015-30]
- [739534]
Ask authors/readers for more resources
This study describes the clinical characteristics of Leber congenital amaurosis and cone-rod dystrophy associated with the GUCY2D gene. The study found that Leber congenital amaurosis presents in infancy, while vision loss is progressive and becomes severe during mid-to-late adulthood. The study also identifies potential therapeutic endpoints and optimal patient selection.
Objective: To describe the spectrum of Leber congenital amaurosis (LCA) and cone-rod dystrophy (CORD) associated with the GUCY2D gene and to identify potential end points and optimal patient selection for future therapeutic trials.Design: International, multicenter, retrospective cohort study.Subjects: Eighty-two patients with GUCY2D-associated LCA or CORD from 54 families.Methods: Medical records were reviewed for medical history, best-corrected visual acuity (BCVA), ophthalmoscopy, visual fields, full-field electroretinography, and retinal imaging (fundus photography, spectral -domain OCT [SD-OCT], fundus autofluorescence).Main Outcomes Measures: Age of onset, evolution of BCVA, genotype-phenotype correlations, anatomic characteristics on funduscopy, and multimodal imaging.Results: Fourteen patients with autosomal recessive LCA and 68 with autosomal dominant CORD were included. The median follow-up times were 5.2 years (interquartile range [IQR] 2.6-8.8 years) for LCA and 7.2 years (IQR 2.2-14.2 years) for CORD. Generally, LCA presented in the first year of life. The BCVA in patients with LCA ranged from no light perception to 1.00 logarithm of the minimum angle of resolution (logMAR) and remained relatively stable during follow-up. Imaging for LCA was limited but showed little to no structural degeneration. In patients with CORD, progressive vision loss started around the second decade of life. The BCVA declined annually by 0.022 logMAR (P < 0.001) with no difference between patients with the c.2513G>A and the c.2512C>T GUCY2D variants (P = 0.798). At the age of 40 years, the probability of being blind or severely visually impaired was 32%. The integrity of the ellipsoid zone (EZ) and that of the external limiting membrane (ELM) on SD-OCT correlated signifi-cantly with BCVA (Spearman r = 0.744, P = 0.001, and r = 0.712, P < 0.001, respectively) in those with CORD.Conclusions: Leber congenital amaurosis associated with GUCY2D caused severe congenital visual impairment with relatively intact macular anatomy on funduscopy and available imaging, suggesting long pres-ervation of photoreceptors. Despite large variability, GUCY2D-associated CORD generally presented during adolescence, with a progressive loss of vision, and culminated in severe visual impairment during mid-to-late adulthood. The integrity of the ELM and EZ may be suitable structural end points for therapeutic studies of GUCY2D-associated CORD. Ophthalmology Retina 2022;6:711-722 (c) 2022 by the American Academy of Ophthalmology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available